AnishBadwe

200 EMA Crossover repeating itself + Great earnings expectations

做多
AnishBadwe 已更新   
NASDAQ:AVXL   Anavex Life Sciences Corp.
The 200 EMA crossover has occurred again! This time we have positive expectations of earnings as well. A good recipe for gains.
Keeping the analysis simple.

Target price: 3.5+
评论:
Stop has been placed at 2.61, below the downtrend's low.
评论:
Things not looking good as AVXL failed to hold above the 200 EMA for a second time.
交易结束:到达止损
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。